1
Angelo M Morella, Mark C Fisher: Sustained release pharmaceutical composition. F H Faulding & Co, Darby & Darby, April 13, 1993: US05202128 (185 worldwide citation)

The present invention relates to a pharmaceutical pellet composition having a core element including at least one highly soluble active ingredient and a core coating which is partially soluble at a highly acidic pH. The pharmaceutical composition provides a slow release of active ingredient at a hig ...


2
Angelo M Morella, Mark C Fisher: Sustained release pharmaceutical composition. F H Faulding & Co, Darby & Darby, January 3, 1995: US05378474 (160 worldwide citation)

The present invention relates to a pharmaceutical pellet composition having a core element including at least one highly soluble active ingredient and a core coating which is partially soluble at a highly acidic pH. The pharmaceutical composition provides a slow release of active ingredient at a hig ...


3
Angelo M Morella, Mark C Fisher: Sustained release pharmaceutical composition. F H Faulding & Co, Darby & Darby, July 19, 1994: US05330766 (154 worldwide citation)

The present invention relates to a pharmaceutical pellet composition having a core element including at least one highly soluble active ingredient and a core coating which is partially soluble at a highly acidic pH. The pharmaceutical composition provides a slow release of active ingredient at a hig ...


4
Morella Angel Mario, Fisher Mark Christopher: Sustained release pharmaceutical composition.. Faulding F H &, July 11, 1990: EP0377518-A2 (118 worldwide citation)

A sustained release pharmaceutical pellet composition suitable for treating pain-associated conditions in patients comprises a core element including at least one active ingredient of high solubility; and a core coating for the core element which is partially soluble at a highly acidic pH to provide ...


5
Hiroitsu Kawata, Masayoshi Aruga, Tadayoshi Ohmura, Takashi Sonobe, Satoru Yoneya, Chiharu Sone: Sustained release pharmaceutical composition of solid medical material. Yamanouchi Pharmaceutical, Burgess Ryan & Wayne, September 13, 1983: US04404183 (115 worldwide citation)

Sustained release pharmaceutical compositions of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl ...


6
Hiroitsu Kawata, Masayoshi Aruga, Tadayoshi Ohmura, Takashi Sonobe, Satoru Yoneya, Chiharu Sone: Sustained release pharmaceutical composition of solid medical material. Yamanouchi Pharmaceutical, Burgess Ryan and Wayne, August 10, 1982: US04343789 (108 worldwide citation)

Sustained release pharmaceutical composition of a solid medical material which contains an amorphous solid medical material, polyethylene oxide, and at least one basic substance selected from the group consisting of hydroxypropylmethyl cellulose, hydroxypropyl cellulose, methyl cellulose, polyvinyl ...


7
Arthur I Cohen, James S Y Sim, Maurice H Van Horn, Stanley E Gordesky, Stanley I Gordon: Sustained release pharmaceutical composition. Union Corporation, Pollock Vande Sande & Priddy, December 11, 1979: US04178361 (91 worldwide citation)

A sustained release pharmaceutical composition which includes a pharmacological material; a biological binding agent for the pharmacological material; and a matrix of a water-insoluble but water-swellable hydrophilic polymer.


8

9
Morella Angelo Mario, Fisher Mark Christopher: Sustained release pharmaceutical composition.. Faulding F H &, August 10, 1994: EP0609961-A1 (75 worldwide citation)

A sustained release pharmaceutical pellet composition suitable for treating pain-associated conditions in patients comprises a core element including at least one active ingredient having an aqueous solubility of at least 1 in 30; and a core coating for the core element which is partially soluble at ...


10
James McAinsh, Raymond C Rowe: Sustained release pharmaceutical composition. Imperial Chemical, Cushman Darby & Cushman, February 6, 1979: US04138475 (72 worldwide citation)

Sustained release pharmaceutical composition consisting of a hard gelatine capsule containing film coated spheroids, the spheroids comprising propranolol, or a pharmaceutically-acceptable salt thereof, in admixture with non-water-swellable microcrystalline cellulose, and the said spheroids having a ...